U.S. markets closed
  • S&P 500

    4,401.46
    -20.84 (-0.47%)
     
  • Dow 30

    35,058.52
    -85.79 (-0.24%)
     
  • Nasdaq

    14,660.58
    -180.14 (-1.21%)
     
  • Russell 2000

    2,191.83
    -25.09 (-1.13%)
     
  • Crude Oil

    71.89
    +0.24 (+0.33%)
     
  • Gold

    1,799.70
    -0.10 (-0.01%)
     
  • Silver

    24.75
    +0.10 (+0.39%)
     
  • EUR/USD

    1.1822
    +0.0014 (+0.12%)
     
  • 10-Yr Bond

    1.2340
    -0.0420 (-3.29%)
     
  • GBP/USD

    1.3881
    +0.0058 (+0.42%)
     
  • USD/JPY

    109.7700
    -0.6050 (-0.55%)
     
  • BTC-USD

    38,363.72
    +1,399.16 (+3.79%)
     
  • CMC Crypto 200

    898.78
    +22.55 (+2.57%)
     
  • FTSE 100

    6,996.08
    -29.35 (-0.42%)
     
  • Nikkei 225

    27,970.22
    +136.93 (+0.49%)
     

Invest Africa Global Receives Its First Covid-19 Rapid Test Kit In Namibia, Africa

·2 min read

Invest Africa Global Receives Its First Covid-19 Rapid Test Kit In Namibia, Africa

CHEYENNE, WY / ACCESSWIRE / April 27, 2021 / MJ Biotech, Inc. (OTC PINK:MJTV), the first shipment to Invest Africa Global of Covid 19 Rapid Test Kit arrived at Namibia, Africa April 23, 2021. The Rapid Test kit is a Nasal Swab test that produces test results in 10 minutes. This is an exciting time for the Company and for Invest Africa Global, as well. The next step in the process of distribution of the Rapid Test Kit is clearance by the Namibia Government Ministry of Health and Social Services.

The country of Namibia is located on the West coast of Africa and North of South Africa and is home to over 2,400,000 people.

For additional information please contact us at info@mjbiotech.us

Safe Harbor Statement: Some of the statements in this press release may be forward-looking statements or statements of future expectations based on currently available information. Such statements are naturally subject to risks and uncertainties. Factors such as the development of general economic conditions, future market conditions, unusual catastrophic loss events, changes in the capital markets and other circumstances may cause the actual events or results to be materially different from those anticipated by such statements. MJ Biotech Inc. does not make any representation or warranty, express or implied, as to the accuracy, completeness, or updated status of such statements. Therefore, in no case whatsoever will MJ Biotech. Inc. and its affiliate companies be liable to anyone for any decision made or action taken in conjunction with the information and/or statements in this press release or for any related damages.

SOURCE: MJ Biotech, Inc.



View source version on accesswire.com:
https://www.accesswire.com/642396/Invest-Africa-Global-Receives-Its-First-Covid-19-Rapid-Test-Kit-In-Namibia-Africa